arrow
J

Jean-Philippe Azulay

expert centre for parkinson’s disease
H指数:43
被引数:6,177

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Bilateral gamma knife radiosurgery in severe essential tremor: a prospective trial

双侧伽马刀放射手术治疗严重特发性震颤:一项前瞻性试验

Brain
IF11.7
2026-07-230
OAAI
Effect on Dyskinesia of the Early Combination of Amantadine to Levodopa-Therapy in Parkinson's Disease: A Randomized, Placebo-Controlled Study (PREMANDYSK)

早期将金刚烷胺与左旋多巴疗法联合应用于帕金森病对运动障碍的影响:一项随机、安慰剂对照研究(PREMANDYSK)

2025-11-010
OAAI
Comparison of tetrabenazine, tiapride and olanzapine in Huntington’s disease: a one-year French randomized multicenter study (Neuro-HD)

四氢苯并二氮䓬、硫必利和奥氮平在亨廷顿病中的比较:一项为期一年的法国多中心随机研究(Neuro-HD)

2025-09-030
PREAI
Exploring the link between personality dimensions and non-motor fluctuations in Parkinson's disease

探索人格维度与非运动波动在帕金森病中的关联

2025-06-270
OA
Motor and Non-motor Complications Following Different Early Therapies in Parkinson's Disease: Longitudinal Analysis of Real-Life Clinical and Therapeutic Data from the French NS-PARK Cohort

帕金森病不同早期疗法后的运动和非运动并发症:基于法国NS-PARK队列的真实世界临床和疗治数据的纵向分析

2025-05-250
PRE
Imbalanced motivated behaviors according to motor sign asymmetry in drug-naïve Parkinson's disease

在药物幼稚的帕金森氏病中,根据运动符号不对称的动机行为不平衡

2023-12-012
OAAI
Motivational and cognitive predictors of apathy after subthalamic nucleus stimulation in Parkinson's disease
BRAIN
IF11.7
2023-10-034
PRE
Safety and efficacy of anti-tau monoclonal antibody gosuranemab in progressive supranuclear palsy: a phase 2, randomized, placebo-controlled trial (August, 10.1038/s41591-021-01455-x, 2021)

抗tau单克隆抗体gosuranemab治疗进行性核上性麻痹的安全性和有效性: 一项2期,随机,安慰剂对照试验 (8月,10.1038/s41591-021-01455-x,2021)

2022-10-171
OA
Trial of Prasinezumab in Early-Stage Parkinson's Disease

Prasinezumab在早期帕金森病中的试验

2022-08-04170
OA
Fatigue in de novo Parkinson's Disease: Expanding the Neuropsychiatric Triad?

新发帕金森病的乏力: 扩大神经精神三联征?

2022-05-2410
OA